— Know what they know.
Not Investment Advice

REPL NASDAQ

Replimune Group, Inc.
1W: +5.9% 1M: +130.0% 3M: -39.6% YTD: -41.4% 1Y: -43.2% 3Y: -71.8% 5Y: -85.1%
$4.91
-0.31 (-5.94%)
 
Weekly Expected Move ±31.0%
$2 $4 $5 $7 $8
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 60 · $405.4M mcap · 76M float · 9.36% daily turnover · Short 36% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$262M -11.4% ▼
Net Income
-$247M -14.6% ▼
EPS (Diluted)
$-3.07 +5.2% ▲
EBITDA
-$254M -11.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$4M$5M$0$0$0
Gross Profit-$4M-$5M$0$0$0
Gross Margin
R&D Expenses$57M$81M$127M$175M$189M
SG&A Expenses$21M$36M$0$0$0
Operating Expenses$79M$117M$177M$235M$262M
Operating Income-$83M-$121M-$177M-$235M-$262M
Operating Margin
Interest Expense$3M$2M$4M$7M$8M
Income Before Tax-$84M-$121M-$174M-$215M-$247M
Tax Expense-$3M-$3M$288K$408K$468K
Net Income-$81M-$118M-$174M-$216M-$247M
Net Margin
EPS (Diluted)$-1.75$-2.26$-2.99$-3.24$-3.07
EBITDA-$76M-$114M-$172M-$228M-$254M
Shares Outstanding46M52M58M67M81M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms